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Abstract: I n t r o d u c t i o n: Complications occurring aft er neurosurgical procedures which lead to re-
operations are associated with poor treatment outcomes. Th e aim of our study was to establish predictive 
factors of unplanned early reoperations aft er intracranial meningioma removal.
M a t e r i a l s  a n d  M e t h o d s: We retrospectively analyzed 177 patients who underwent craniotomy 
due to an intracranial meningioma. Early reoperation was defi ned as reoperation during the same hospital 
stay. We used a χ2 test for proportional values and t-test and Mann-Whitney U tests as appropriate for 
continuous variables. To determine the potential predictors of early reoperation we used univariate and 
multivariate logistic regression analyses.
R e s u l t s: A total of 13 (7.34%) patients underwent unplanned early reoperation. Th ese patients un-
derwent retrosigmoid craniotomies (25.00% vs. 6.40%; p = 0.047), suff ered from ischemic heart disease 
(66.67% vs. 6.64%; p <0.01) and atrial fi brillation (60.00% vs. 6.25%; p <0.01), were receiving heparin 
(50.00% vs. 6.74%; p <0.01) and anticoagulants (66.67% vs. 6.21%; p <0.01) signifi cantly more oft en than 
the general study population. In multivariate logistic regression analysis anticoagulant use (OR: 31.463; 
95% CI: 1.139–868.604; p = 0.04) and retrosigmoid craniotomy (OR: 6.642; 95% CI: 1.139–38.73; p = 0.034) 
remained independently associated with a higher risk of early reoperation.
C o n c l u s i o n s: Patients who underwent retrosigmoid craniotomy, those with a history of ischemic heart 
disease or atrial fi brillation and those who take heparin or anticoagulants are more likely to require early re-
operation. Retrosigmoid craniotomy and anticoagulant use are independent risk factors for early reoperation.
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Introduction
Intracranial meningiomas are one of the most frequently diagnosed primary brain 
tumors [1]. Th ey are typically benign and account for about 33% of all primary brain 
tumors [2]. Th eir incidence increases with age and they aff ect women more commonly 
than men [3, 4]. One of the most prevalent problems of meningioma surgeries is a high 
rate of recurrence of the meningioma. Benign meningiomas have a  risk of recurrence 
between 10–32% within 10 years of the primary surgery [5, 6]. One of the strongest 
predictors of recurrence is incomplete resection [7, 8]. Th erefore it is important to 
achieve total resection of the tumor. However, these surgeries may carry a signifi cant risk 
of complications such as postoperative bleeding, brain edema, vascular insults (arterial 
or venous), liquorrhea or increased intracranial pressure. Th e  possible complications 
of meningioma removal have been analyzed before in terms of postoperative bleeding 
[9] and venous infarcts [10, 11]. However, aft er a  thorough search of the literature, 
there are very few studies that analyzed all possible complications which might require 
reoperation in terms of intracranial meningioma surgery. Th erefore we decided to fi nd 
predictive factors of early reoperation aft er benign meningioma resection.
Patients and Methods
We retrospectively analyzed 181 patients hospitalized between January 2014 and 
January 2016 who underwent craniotomy for intracranial meningioma. We included 
in our study only patients with histologically confi rmed benign meningiomas. From 
their medical records we obtained detailed medical histories including previous 
diseases, current medications and blood test results taken up to 24 hours before the 
surgery. We also obtained tumour characteristics, details about the surgery including 
date, cause, type and side of the craniotomy and whether the doctor who performed 
the surgery and their assistant were board certifi ed specialists in neurosurgery. Early 
unplanned reoperation was defi ned as reoperation that occurred during the same 
hospitalization. Completeness of tumour resection was assessed using the Simpson 
Grading scale [12]. All patients in our department are routinely prepared for surgery 
by cessation of antiplatelets and anticoagulants. Cessation of these drugs is preformed 
14  days prior to any surgery and patients are switched to low-molecular weight 
heparin which is then ceased 24 hours prior to the surgery. 
Statistical analysis
For statistical analysis we performed a  χ2 test for proportional values and T-test and 
Mann-Whitney U tests as appropriate for continuous variables. To determine the 
potential predictive factors of reoperation aft er benign meningioma removal we used 
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univariate and multivariate logistic regression analyses. P-values less than 0.05 were 
considered to be statistically signifi cant. A threshold p-value of <0.1 was used to 
qualify data for multivariate logistic regression analysis. Forward logistic regression 
analysis was followed by backwards logistic regression analysis. To perform all 
statistical analyses we used RStudio v.10 for Windows (Statsoft , Poland).
Results 
Our study group consisted of 181 patients with 132 (72.92%) of them females. 
The  mean age was 60.28 ± 12.61 years and the mean Simpson grade was 
1.86 ± 0.76. Th e  meningioma location is shown in Figure 1. Th e  most common 
complication that required early reoperation was postoperative hemorrhage 
(46.15%), followed by liquorrhea (38.46%) and brain edema or venous infarction 
(15.38%). A total of   13  (7.18%) patients required early reoperation. Th ese patients 
suffered from ischemic heart disease (16.67% vs. 0.59%; p <0.01) and atrial 
fi brillation (25%  vs.  1.18%; p <0.01) signifi cantly more oft en than the general 
study population. Th ey also took β-blockers (33.33% vs. 11.83%; p = 0.03) and 
angiotensin-converting-enzyme (ACE) inhibitors (33.33% vs. 10.06%; p = 0.01) 
signifi cantly more oft en (Table 1). Th e  result of the coagulation parameters stayed 
within normal range (Table 2) Patients who underwent early reoperation were more 
likely to have undergone a  retrosigmoid craniotomy (16.67% vs. 3.55%; p = 0.03). 
We found no statistically signifi cant diff erence between meningioma location and 
Simpson grade (2.00 ± 0.50 vs. 1.85 ± 0.78; p = 0.57) in terms of early reoperative 
risk (Table 3). In multivariate logistic regression analysis, aft er adjustment for all 
possible confounders, anticoagulants (OR: 31.463; 95% CI:   1.139–868.604; p = 0.04) 
and retrosigmoid craniotomy (OR: 6.642; 95% CI: 1.139–38.73; p = 0.034) remained 
independently associated with a higher risk of early reoperation (Table 3).
Fig. 1. Intracranial meningioma location. 
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(n = 181) p-value
Age [years] ± SD 61.75 ± 10.44 60.14 ± 12.77 0.67
Female gender [%] 66.67 73.37 0.61
Medical history
Hypertenstion [%] 50.00 44.38 0.71
Diabetes mellitus [%]  0.00 16.57 0.13
Cigarette smoking [%]  0.00 14.79 0.15
Alcohol abuse [%]  0.00  4.14 0.47
Ischemic heart disease [%] 16.67  0.59 <0.01
History of heart attack [%]  0.00  1.18 0.70
History of ischemic stroke [%] 16.67  4.14 0.053
Atrial fi brillation [%] 25.00  1.18 <0.01
Lungs diseases [%]  0.00  3.55 0.51
Hyperthyroidism [%]  0.00  2.37 0.59
Hypothyroidism [%]  8.33  6.51 0.81
Hypercholesterolemia [%]  8.33  2.96 0.31
Current medications
Acetylosalicylic acid [%]  0.00  3.55 0.51
Beta-blockers [%] 33.33 11.83 0.03
Angiotensin-converting-enzyme inhibitors [%] 33.33 10.06 0.01
AT2-blockers [%]  0.00  2.37 0.59
Calcium channel blockers [%]  8.33  8.88 0.95
Diuretics [%] 25.00 14.79 0.34
Steroids [%]  8.33  7.10 0.87
Antidiabetic therapy [%]  0.00  5.92 0.39
Insulin [%]  0.00  3.55 0.51
Heparin [%]  8.33  0.59 0.01
Anticoagulants [%]  8.33  1.18 0.04
Nitrates [%]  0.00  0.59 0.79
Statins [%]  0.00  7.69 0.32
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(n = 181) p-value
Blood test results preceding surgery
White Blood Cell count [103/μl] ± SD 9.63 ± 3.06 8.97 ± 6.65 0.75
Red Blood Cell count [103/μl] ± SD 4.57 ± 0.51 4.60 ± 0.50 0.85
Mean Corpuscular Hemoglobin [pg] ± SD 89.08 ± 3.95 87.12 ± 4.19 0.13
Hematocrit [%] ± SD 11.61 ± 0.78 11.56 ± 0.79 0.84
Mean Corpuscular Hemoglobin Concentration [g/dl] ± SD 30.21 ± 1.41 29.51 ± 1.64 0.17
Mean Corpuscular Volume [μm3] ± SD 6.60 ± 2.01 6.17 ± 2.80 0.62
Platelet count [103/μl] ± SD 223.09 ± 62.81 249.90 ± 66.32 0.19
Prothrombin Time [s] ± SD 4.21 ± 0.38 4.38 ± 0.46 0.23
International Normalized Ratio ± SD 28.29 ± 4.46 27.67 ± 3.92 0.62
Activated Partial Prothrombin Time [s] ± SD 13.82 ± 1.68 13.58 ± 1.61 0.64
Creatinine [μmol/l] ± SD 1.03 ± 0.07 1,00 ± 0.07 0.26
Glucose [mmol/l] ± SD 66.27 ± 13.43 77.61 ± 50.19 0.46




(n = 181) p-value
Surgery during weekend [%] 16.67 21.30 0.70
“On call” hours of surgery [%]  0.00  1.80 0.72
Bone fl ap removal [%] 80.00 86.36 0.57
Operator specialized [%] 83.33 89.35 0.52
Assistant specialized [%] 41.67 41.42 0.99
Simpson grade 2.00 ± 0.50 1.85 ± 0.78 0.57
Craniotomy type
Fronto-temoporo-parietal [%]  0.00  4.73 0.44
Fronto-temporo-occipital [%]  0.00  0.59 0.79
Fronto-parietal [%] 16.67 19.53 0.81
Parieto-temporal [%]  0.00  5.33 0.41




(n = 181) p-value
Parieto-occipital [%]  8.33  2.37 0.22
Parietal [%] 16.67  9.47 0.42
Frontal [%] 33.33 21.89 0.36
Pterional [%]  8.33 17.16 0.43
Suboccipital [%]  0.00 12.43 0.19
Retromastoid [%] 16.67  3.55 0.03
Right side [%] 41.67 55.03 0.37
Left  side [%] 58.33 53.85 0.76
Meningioma location
Parasaggital [%] 25.00 12.43 0.21
Cerebral falx [%]  0.00 14.20 0.16
Olfactory groove [%] 16.67 14.20 0.81
Cerebellar tentorium and petrous bone [%]  8.33 13.02 0.64
Pterional [%]  0.00  7.10 0.34
Convexity [%] 25.00 14.20 0.31
Confl uence of sinuses [%]  8.33  3.55 0.41
Tuberculum sellae [%]  0.00  4.73 0.44
Sphenoid wing [%] 16.67 15.98 0.95
Intraventricular [%]  0.59  0.00 0.78
Discussion
We found that ischemic heart disease, atrial fi brillation, prior beta-blocker and ACE 
inhibitor use, and anticoagulant and heparin use are associated with an increased 
risk of reoperation aft er intracranial meningioma surgery. Aft er our multivariant 
regression we found that retrosigmoid craniotomy and a  history of anticoagulant 
use are independently associated with an increased risk of early reoperation aft er 
intracranial meningioma surgery.
In the presented study our frequency of reoperation was 7.18%. In terms of all 
brain tumors, the complication rate was about 17% in the Rolston et al. study and 
Table 3. Cont.
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13% in the Sawaya et al. study [13, 14]. McLaughlin et al. assessed these rates at less 
than 1% [15]. 
In our study the rate of unplanned reoperations due to postoperative hemorrhage 
was about 3%. Nittiby et al. established the rate at about 2% [16] for all cranial neuro-
surgical procedures and Kalfas et al. established about 1% [17]. In terms of reoperations 
on meningiomas due to postoperative hemorrhage, Gerlach et al. established the rate at 
about 7% [9].
An interesting finding of our study was an independent association between 
retrosigmoid craniotomy and a higher risk of early reoperation. Th ere is limited data 
presented in other studies concerning type of craniotomy and risk of complications 
[9, 13–17]. However, the retrosigmoid craniotomy is common surgical approach to 
challenging tentorial and petroclival meningiomas. An infratentorial location of the 
tumor was established to be associated with a higher risk of regional complications in 
the Brell et al. study [18].
Another fi nding of our study was an independent association between heparin 
or anticoagulant intake and a  higher risk of early reoperation. Pre-operative 
anticoagulant therapy has been proven to be a risk factor for postoperative bleeding 
in other surgical specialties [19–21]. Also Nittiby et al. determined in their study 
that anticoagulant intake is a  risk factor of postoperative bleeding in terms of 
neurosurgical procedures [16]. However these results were not confi rmed by other 
researchers [15–17]. Similarly Gerlach et al. found no signifi cant diff erence between 
preoperative coagulation parameters and a  higher risk of postoperative bleeding in 
patients operated on due to a meningioma [9].
In our study we also found that ischemic heart disease and atrial fi brillation were 
associated with an increased the risk of early reoperation. As both of those diseases 
can be managed with anticoagulant use, this association might be explained by the 
above mentioned association. Other researchers focuse limited attention to such 
factors [9, 13–17]. However, in the Rolston et al. study a history of ischemic stroke, 
which is also correlated with anticoagulant intake, was determined as a  predictive 
factor of complications aft er neurosurgical procedures [13].
Our study also showed that patients who took β-blockers and ACE inhibitors 
were at a  higher risk of early reoperation. In Rolston et al. study, patients who 
suff ered from arterial hypertension and took antihypertensive drugs had a higher risk 
of complications [16]. Arterial hypertension was also a  risk factor for postoperative 
intracranial bleeding in the Basali et al. study [22]. However, we found no association 
between early reoperation and a history of arterial hypertension. In terms of specifi c 
antihypertensive drugs, Smith et al. found that ACE inhibitor intake increases the 
risk of intraoperative hypotensive episodes [23]. Also Cittanova et al. discovered that 
chronic intake of these drugs is associated with a higher risk of postoperative renal 
impairment [24].
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Conclusions
In conclusion, the presence of ischemic heart disease or atrial fi brillation, preoperative 
anticoagulant therapy, ACE inhibitor or β-blocker intake and retromastoid craniotomy 
are risk factors of early reoperation aft er benign meningioma removal and should be 
taken into consideration before surgery.
Our research was limited by the size of the study group which involved patients 
from only one neurosurgical facility. Further analysis should be performed on a larger 
and more varied group of patients. Despite our limitations, this is the fi rst study that 
analyses the full range of possible risks for neurosurgical complications in terms of 
benign meningioma removal. 
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